Pipeline
| Area | Indication | Product Type | Target | Pipeline | Discovery | Preclinical | IND | Phase |
|---|---|---|---|---|---|---|---|---|
| Immuno-oncology | HCC | Polyclonal T cells | Neoags | TCME01 | 2025 / 4Q | |||
| Polyclonal T cells | Neoags + ISTx | TCME01x | ||||||
| mRNA TCR-T cells | HLA-A2x/p53 | TCME04p | ||||||
| Neuroinflammation | AD/ALS | Polyclonal Tregs | Autoreactive T | TCME05 | ||||